Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03908736 · ClinicalTrials.gov registry record · NA
Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
A NA study of Immune System Disorder and DNA Damage, sponsored by University of New Mexi.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03908736 is a NA study of Immune System Disorder and DNA Damage that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03908736, a NA study of Immune System Disorder and DNA Damage, is actively recruiting participants, sponsored by University of New Mexi.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study to assess the effect of dietary zinc supplementation to mitigate biomarkers of metal toxicity in exposed tribal populations.
Conditions Studied
Interventions
- DRUG Zinc Picolinate 15 Mg
Study Locations (1)
New Mexico
- University of New Mexico Health Sciences Center - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-05-19 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03908736
The ClinicalTrials.gov registry entry for NCT03908736 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Immune System Disorder appearing as the primary indexed condition, and to 1 intervention - of which Zinc Picolinate 15 Mg is the first listed.
NCT03908736 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.
Frequently Asked Questions
What is clinical trial NCT03908736 about?
NCT03908736 is a clinical study titled "Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation". This is a study to assess the effect of dietary zinc supplementation to mitigate biomarkers of metal toxicity in exposed tribal populations.
What is the current status of trial NCT03908736?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2019-05-19. Estimated completion is 2027-12.
What conditions does trial NCT03908736 study?
This clinical trial studies the following conditions: Immune System Disorder, DNA Damage.
What interventions are being tested in trial NCT03908736?
The interventions under investigation include: Zinc Picolinate 15 Mg (DRUG).
Who is sponsoring clinical trial NCT03908736?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03908736 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Immune System Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.